http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1365771-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f001dd344c389685061ae7f82bcb93da
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2001-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14fa3b9a406769d4114886ae5223b09e
publicationDate 2005-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1365771-A4
titleOfInvention METHOD OF TREATING CERTAIN EYE DISEASES
abstract The present invention is directed to methods for treating diminished visual acuity in a human patient who has been diagnosed as suffering from a disease or disorder of the posterior region of the eye. These involve topical application to the eye, an amount of acetylcholine esterase inhibitor containing composition is carried out so that it is sufficient to provide a therapeutic benefit to alleviate the diminished visual acuity in the human patient. The composition is administered at bedtime after an eye straining work for about 20 minutes.
priorityDate 2001-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412509
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413074
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397752
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11980904

Total number of triples: 47.